Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS

Reuters2025-12-02

Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS

Hologic Inc. has announced that 11 studies featuring the Breast Cancer Index $(BCI)$ Test will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS). The studies include new data on premenopausal women and comparative analyses of BCI Testing with the 21-gene assay for extended endocrine therapy decision-making in early-stage, hormone receptor-positive breast cancer. These findings are intended to support personalized treatment recommendations and explore the expanded utility of the BCI Test across diverse patient subgroups and sample types. The results from these studies have not yet been presented and are scheduled for future presentation at SABCS 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201515278) on December 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588055891?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 21:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588055891","market":"nz","top_or_hot":-1,"title":"Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hologic Inc. has announced that 11 studies featuring the Breast Cancer Index <a href=\"https://laohu8.com/S/BCI\">$(BCI)$</a> Test will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS). The studies include new data on premenopausal women and comparative analyses of BCI Testing with the 21-gene assay for extended endocrine therapy decision-making in early-stage, hormone receptor-positive breast cancer. These findings are intended to support personalized treatment recommendations and explore the expanded utility of the BCI Test across diverse patient subgroups and sample types. The results from these studies have not yet been presented and are scheduled for future presentation at SABCS 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201515278) on December 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-02 21:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hologic Inc. has announced that 11 studies featuring the Breast Cancer Index <a href=\"https://laohu8.com/S/BCI\">$(BCI)$</a> Test will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS). The studies include new data on premenopausal women and comparative analyses of BCI Testing with the 21-gene assay for extended endocrine therapy decision-making in early-stage, hormone receptor-positive breast cancer. These findings are intended to support personalized treatment recommendations and explore the expanded utility of the BCI Test across diverse patient subgroups and sample types. The results from these studies have not yet been presented and are scheduled for future presentation at SABCS 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201515278) on December 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1951198990.SGD","symbol_name":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL63CzWj:1","article_id":"2588055891","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588055891","pubTimestamp":1764681018,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Hologic Inc. has announced that 11 studies featuring the Breast Cancer Index  Test will be presented at the 2025 San Antonio Breast Cancer Symposium . The studies include new data on premenopausal women and comparative analyses of BCI Testing with the 21-gene assay for extended endocrine therapy decision-making in early-stage, hormone receptor-positive breast cancer. These findings are intended to support personalized treatment recommendations and explore the expanded utility of the BCI Test across diverse patient subgroups and sample types. The results from these studies have not yet been presented and are scheduled for future presentation at SABCS 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the origina","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","HOLX":"豪洛捷","BK4082":"医疗保健设备","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4588":"碎股","LU1923622614.USD":"Natixis Thematics Meta R/A USD","BK4585":"ETF&股票定投概念","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD"},"translate_title":"Hologic公布新数据，显示乳腺癌指数测试在2025年SABCS上的效用扩大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HOLX":0.9},"content_text":"Hologic Unveils New Data Showing Expanded Utility of Breast Cancer Index Test at 2025 SABCS\n    \n\n        Hologic Inc. has announced that 11 studies featuring the Breast Cancer Index $(BCI)$ Test will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS). The studies include new data on premenopausal women and comparative analyses of BCI Testing with the 21-gene assay for extended endocrine therapy decision-making in early-stage, hormone receptor-positive breast cancer. These findings are intended to support personalized treatment recommendations and explore the expanded utility of the BCI Test across diverse patient subgroups and sample types. The results from these studies have not yet been presented and are scheduled for future presentation at SABCS 2025.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201515278) on December 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588055891","isCrawlerRequest":true}